Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 1, 1996, Pages 93-101

  Woods, Melody L ^a   Koch, Cameron J ^b   Lord, Edith M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

2 Nitroimidazole; EFS; EMT6 tumors; Flow cytometric analysis; Tumor hypoxia

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 NITROIMIDAZOLE DERIVATIVE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL HYPOXIA; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0030032917     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02006-3     Document Type: Article

References (33)

1. Chapman, J. D. Hypoxic sensitizers - Implications for radiation therapy. N. Engl. J. Med. 301:1429-1432; 1979.
2. Chapman, J. D.; Baer, K.; Lee, J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 43:1523-1528; 1983.
3. DeVita, V. T. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer. Cancer 51:1209-1220; 1983.
4. Franko, A. J.; Koch, C. J. The radiation response of hypoxic cells in EMT6 spheroids in suspension culture does model data from EMT6 tumors. Radiat. Res. 96:496-504; 1983.
5. Franko, A. J.; Koch, C. J.; Garrecht, B. M.; Sharplin, J.; Howorko, J. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res. 47:5367-5376; 1987.
6. Freyer, J. P.; Schor, P. L. Automated selective dissociation of cells from different regions of multicellular spheroids. In Vitro Cell Dev. 25:9-19; 1989.
7. Freyer, J. P.; Sutherland, R. M. Selective dissociation and characterization of cells from different regions of multicell spheroids. Cancer Res. 40:3956-3965; 1980.
8. Giesbrecht, J. L.; Wilson, W. R.; Hill, R. P. Radiobiological studies of cells in multicellular spheroids using a sequential trypsinization technique. Radiat. Res. 86:368-386; 1981.
9. Gray, L. H.; Conger, A. D.; Ebert, M.; Hornsey, S.; Scott, O. C. A. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26:638-648; 1953.
10. Hodgkiss, R. J.; Jones, G.; Long, A.; Parrick, J.; Smith, K. A.; Stratford, M. R. L. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br. J. Cancer 63:119-125; 1991.
11. Kallinowski, F.; Zander, R.; Hockel, M.; Vaupel, P. Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int. J. Radiat. Oncol. Biol. Phys. 19:953-961; 1990.
12. Kennedy, K. A. Hypoxic cells as specific targets for chemotherapy. Anti-Cancer Drug Design 2:181-194; 1987.
13. Koch, C. J. A thin-film culturing technique allowing rapid gas-liquid equilibration (6 seconds) with no toxicity to mammalian cells. Radiat. Res. 97:434-442; 1984.
14. Koch, C. J. The reductive activation of nitroimidazoles; Modification by oxygen and other redox-active molecules in cellular systems. In: Adams, G. E.; Breccia, A.; Fielden, E. M.; Wardman, P., eds. Selective activation of drugs by redox processes. NATO Series A. New York: Plenum Press; 1990:237-247.
15. Koch, C. J.; Evans, S. M.; Lord, E. M. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoroproply)acetamide]: Analysis of drug adducts by fluorescent antibodies vs. bound radioactivity. Br. J. Cancer (in press) 1995.
16. 19F magnetic resonance spectroscopy. Cancer Commun. 3:133-193; 1991.
17. Lord, E. M.; Penney, D. P.; Sutherland, R. M.; Cooper, J. R. A. Morphological and functional characteristics of cells infiltrating and destroying tumor multicellular spheroids in vivo. Virchows Arch. B Cell. Pathol. 31:103-116; 1979.
18. Lord, E. M.; Harwell, L.; Koch, C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res. 53:5271-5276; 1993.
19. Mueller-Klieser, W. Microelectrode measurements of oxygen tension distributions in multicellular spheroids cultured in spinner flasks. In: Acker, H.; Carlsson, J.; Durand, R.; Sutherland, R. M. , ed. Recent Results In Cancer Research: Spheroids in Cancer Research. Berlin: Springer-Verlag; 1984:134-149.
20. Parliament, M. B.; Chapman, J. D.; Urtasun, R. C.; McEwan, A. J.; Golberg, L.; Mercer, J. R.; Mannan, R. H.; Wiebe, L. I. Noninvasive assessment of human tumour hypoxia with I-iodoazomycin arabinoside: Preliminary report of a clinical study. Br. J. Cancer 65:90-95; 1992.
21. Raleigh, J. A.; Franko, A. J.; Treiber, E. O.; Lunt, J. A.; Allen, P. S. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumours in BALB/c mice: Detection by F-19 nuclear magnetic resonance at 2.35 T. Int. J. Radiat. Oncol. Biol. Phys. 10:1337-1340; 1984.
22. Raleigh, J. A.; La Dine, J. K.; Cline, J. M.; Thrall, D. E. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. Br. J. Cancer 69:66-71; 1994.
23. Raleigh, J. A.; Miller, G. G.; Franko, A. J.; Koch, C. J.; Fuciarelli, A. F.; Kelley, D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer 56:395-400; 1987.
24. Rasey, J. S.; Grunbaum, Z.; Magee, S.; Nelson, N. J.; Olive, P. L.; Durand, R. E.; Krohn, K. A. Characterization of radiolabelled fluoromisonidazole as a probe for hypoxic cells. Radiat. Res. 111:292-304; 1987.
25. Rockwell, S. C.; Kallman, R. F.; Fajardo, L. F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 49:735-749; 1972.
26. Rumsey, W. L.; Vanderkooi, J. M.; Wilson, D. F. Imaging of phosphorescence: A novel method for measuring oxygen distribution in perfused tissue. Science 241:1649-1651; 1988.
27. Sugano, T.; Oshino, N.; Chance, B. Mitochondrial functions under hypoxic conditions: The steady states of cytochrome c reduction and of energy metabolism. Biochim. Biophys. Acta 347:340-358; 1974.
28. Sutherland, R. M. Cell and environmental interactions in tumor microregions: The multicellular spheroid model. Science 240:177-184; 1988.
29. Taylor, Y. C.; Rauth, A. M. Differences in the toxicity and metabolism of 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. Cancer Res. 38:2745-2752; 1978.
30. Urtasun, R. C.; Koch, C. J.; Franko, A. J.; Raleigh, J. A.; Chapman, J. D. A novel technique for measuring human tissue hypoxia at the cellular level. Br. J. Cancer 54:453-457; 1985.
31. VanOs-Corby, D. J.; Koch, C. J.; Chapman, J. D. Is misonidazole binding to mouse tissues a measure of cellular pO2? Biochem. Pharmacol. 36:3487-3494; 1987.
32. Varghese, A. J.; Gulyas, S.; Mohindra, J. K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res. 36:3761-3765; 1976.
33. Vaupel, P.; Frinak, S.; Bicher, H. I. Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res. 55:141-146; 1988.